Place any order that is greater than $500 and get a mystery box from ACROBiosystems!
Place any order that is greater than $500 and get a mystery box from ACROBiosystems!
Place any order that is greater than $500 and get a mystery box from ACROBiosystems!
Place any order that is greater than $500 and get a mystery box from ACROBiosystems!
Cat. No. | Species | Product Description | Structure | Purity | Feature |
---|---|---|---|---|---|
B73-C52Ha | Cynomolgus | Cynomolgus B7-H3 / CD276 Protein, His Tag | ![]() |
![]() ![]() |
![]() ![]() |
B73-H82F5 | Human | Biotinylated Human B7-H3 / CD276 Protein, Fc,Avitag™ | ![]() |
![]() ![]() |
![]() ![]() |
B73-H82E6 | Human | Biotinylated Human B7-H3 / CD276 Protein, Avitag™,His Tag | ![]() |
![]() ![]() |
![]() ![]() |
B73-M52H4 | Mouse | Mouse B7-H3 / CD276 Protein, His Tag | ![]() |
![]() ![]() |
![]() ![]() |
B73-M5255 | Mouse | Mouse B7-H3 / CD276 Protein, Fc Tag | ![]() |
![]() ![]() |
![]() ![]() |
B73-H52E2 | Human | Human B7-H3 / CD276 Protein, His Tag | ![]() |
![]() ![]() |
![]() ![]() |
B73-H5253 | Human | Human B7-H3 / CD276 Protein, Fc Tag | ![]() |
![]() ![]() |
![]() ![]() |
Name | Research Code | Research Phase | Company | Indications | Clinical Trials |
---|---|---|---|---|---|
Monoclonal antibody 8H9 I-131 | 131-I-8H9; 8H9-MAb; 131I-8H9-(B7-H3) | Phase Ⅲ | Memorial Sloan-Kettering Cancer Center, Y-mAbs | Neuroblastoma | Details |
DS-5573 | DS-5573; DS-5573a | Phase Ⅰ | Daiichi Sankyo | Solid tumours | Details |
4SCAR-276 | 4SCAR-276 | Phase Ⅱ | Shenzhen Geno-Immune Medical Institute | Solid tumours | Details |
Enoblituzumab | MGA-271,MGA271 | Phase Ⅱ | MacroGenics | Prostate cancer | Details |
SCRI-CARB7H3 | SCRI-CARB7H3,SCRICARB7H3 | Phase Ⅰ | Seattle Children's Hospital | Glioma, Central nervous system tumors | Details |
Monoclonal antibody 8H9 I-124 | 124I-8H9; 124I-8H9-(B7-H3) | Phase Ⅱ | Memorial Sloan-Kettering Cancer Center, Weill Cornell Medical College | Glioma | Details |
MGC-018 | MGC-018 | Phase Ⅱ | MacroGenics | Solid tumours | Details |
B7-H3 CAR-T cell therapy (Zhejiang University) | Phase Ⅱ | Zhejiang University | Glioblastoma | Details | |
DS-7300 | DS-7300 | Phase Ⅱ | Daiichi Sankyo, Sarah Cannon Research Institute | Solid tumours | Details |
Orlotamab | MGD-009; B7-H3 x CD3 | Phase Ⅰ | MacroGenics | Solid tumours | Details |
This web search service is supported by Google Inc.